Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Central anti-diabetic action of biguanide and thizolidinediones in D-glucose fed and streptozotocin-treated mouse models.

Sim YB, Park SH, Kang YJ, Kim SS, Kim CH, Kim SJ, Jung JS, Ryu OH, Choi MG, Suh HW.

Neurosci Lett. 2012 Oct 18;528(1):73-7. doi: 10.1016/j.neulet.2012.08.038. Epub 2012 Aug 28.

PMID:
22960361
[PubMed - indexed for MEDLINE]
2.

Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes.

Cox SL.

Drugs Today (Barc). 2004 Jul;40(7):633-43. Review.

PMID:
15510236
[PubMed - indexed for MEDLINE]
3.

Rosiglitazone/Metformin.

Wellington K.

Drugs. 2005;65(11):1581-92; discussion 1593-4. Review.

PMID:
16033298
[PubMed - indexed for MEDLINE]
4.

Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.

Strowig SM, Raskin P.

Diabetes Obes Metab. 2005 Nov;7(6):633-41. Review.

PMID:
16219007
[PubMed - indexed for MEDLINE]
5.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
6.

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes.

Derosa G, Tinelli C, Maffioli P.

Diabetes Obes Metab. 2009 Dec;11(12):1091-9. doi: 10.1111/j.1463-1326.2009.01087.x. Epub 2009 Sep 17. Review.

PMID:
19765050
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk